Microcap cardio player touts a 'sizable' tech deal with Bayer's BlueRock in wake of 'going concern' alert
A microcap biotech player operating under a “going concern” alert is touting a tie-up with Bayer’s BlueRock, a high-profile outfit exploring the frontiers of cell …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.